Pazopanib Hydrochloride in Treating Patients With Advanced or Progressive Malignant Pheochromocytoma or Paraganglioma

Update Il y a 4 ans
Reference: NCT01340794

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

This phase II trial studies how well pazopanib hydrochloride works in treating patients with advanced or progressive malignant pheochromocytoma or paraganglioma. Pazopanib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor.


Inclusion criteria

  • Extra-Adrenal Paraganglioma,Metastatic Adrenal Gland Pheochromocytoma,Paraganglioma,Recurrent Adrenal Gland Pheochromocytoma

Links